eXoZymes, Inc. (EXOZ) — Working Capital to Net Assets Ratio
eXoZymes, Inc. (EXOZ) has a Working Capital to Net Assets ratio of 33.2% as of March 2026. Working capital of $507.58K (current assets of $2.09 Million minus current liabilities of $1.58 Million) is measured against net assets of $1.53 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See eXoZymes, Inc. (EXOZ) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
eXoZymes, Inc. Working Capital to Net Assets (2021–2025)
This chart shows how eXoZymes, Inc.'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 33.2%, reflecting working capital of $507.58K against net assets of $1.53 Million USD. See eXoZymes, Inc. liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for eXoZymes, Inc. (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for eXoZymes, Inc. from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see EXOZ stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 69.8% | $2.37 Million | $3.40 Million | $3.94 Million | $1.57 Million | ▼ -21.2 pp |
| 2024 | 91.0% | $9.49 Million | $10.42 Million | $10.82 Million | $1.33 Million | ▼ -221.6 pp |
| 2023 | 312.7% | $-1.20 Million | $-384.32K | $1.21 Million | $2.42 Million | ▲ +251.8 pp |
| 2022 | 60.8% | $834.88K | $1.37 Million | $1.47 Million | $634.36K | ▲ +6.9 pp |
| 2021 | 53.9% | $645.56K | $1.20 Million | $1.05 Million | $400.78K | — |